Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1369653 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
Further application of our multivalent approach to drug discovery directed to 5-HT4 receptor agonists is described. Optimization of the linker and secondary binding amine in the indazole-tropane primary binding group series, for binding affinity and functional potency at the 5-HT4 receptor, selectivity over the 5-HT3 receptor, oral pharmacokinetics, and in vivo efficacy in models of GI motility, resulted in the identification of clinical compound TD-2749.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Daniel D. Long, Scott R. Armstrong, David T. Beattie, Seok-Ki Choi, Paul R. Fatheree, Roland A.L. Gendron, Adam A. Goldblum, Patrick P. Humphrey, Daniel G. Marquess, Jeng-Pyng Shaw, Jacqueline A.M. Smith, S. Derek Turner, Ross G. Vickery,